These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Expression and role of urotensin II on the lung of patients with pulmonary hypertension with congenital heart disease]. Rong X; Wu HP; Qiu HX; Ren Y; Zhang YH; Chen Q; Wu RZ; Hu XT Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):689-91. PubMed ID: 23158820 [TBL] [Abstract][Full Text] [Related]
45. [Diagnosis of pulmonary hypertension by pulsed Doppler echocardiography--comparison with cardiac catheterization]. Ge ZM; Zhang Y; Gao DC Zhonghua Nei Ke Za Zhi; 1989 Aug; 28(8):460-2, 508. PubMed ID: 2598727 [TBL] [Abstract][Full Text] [Related]
46. Correlation Between Doppler Echocardiography and Right Heart Catheterization Derived Pulmonary Artery Pressures: Impact of Right Atrial Pressures. Ahmed I; Hassan Nuri MM; Zakariyya AN; Ahmad SM; Ahmed M J Coll Physicians Surg Pak; 2016 Apr; 26(4):255-9. PubMed ID: 27097692 [TBL] [Abstract][Full Text] [Related]
47. [Study on the effect of adrenomedulin and urotensin-II on pulmonary hypertension of patients with congenital heart disease]. Wang T; Li SX; Zhang XQ; Gu XH; Song Y; Zhang G; Wu SM Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(38):2691-5. PubMed ID: 16324296 [TBL] [Abstract][Full Text] [Related]
48. Intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 are increased in the plasma of children with sepsis-induced multiple organ failure. Whalen MJ; Doughty LA; Carlos TM; Wisniewski SR; Kochanek PM; Carcillo JA Crit Care Med; 2000 Jul; 28(7):2600-7. PubMed ID: 10921602 [TBL] [Abstract][Full Text] [Related]
49. High plasma adiponectin is associated with increased pulmonary blood flow and reduced right ventricular function in patients with pulmonary hypertension. Luo D; Chen P; Yang Z; Fu Y; Huang Y; Li H; Chen J; Zhuang J; Zhang C BMC Pulm Med; 2020 Jul; 20(1):204. PubMed ID: 32731857 [TBL] [Abstract][Full Text] [Related]
50. Comparison of endothelial biomarkers according to reversibility of pulmonary hypertension secondary to congenital heart disease. Smadja DM; Gaussem P; Mauge L; Lacroix R; Gandrille S; Remones V; Peyrard S; Sabatier F; Bonnet D; Lévy M Pediatr Cardiol; 2010 Jul; 31(5):657-62. PubMed ID: 20195855 [TBL] [Abstract][Full Text] [Related]
51. Use of ATP-MgCl2 in the evaluation and treatment of children with pulmonary hypertension secondary to congenital heart defects. Brook MM; Fineman JR; Bolinger AM; Wong AF; Heymann MA; Soifer SJ Circulation; 1994 Sep; 90(3):1287-93. PubMed ID: 8087937 [TBL] [Abstract][Full Text] [Related]
52. Risk Factors for Adverse Events in Children with Pulmonary Hypertension Undergoing Cardiac Catheterization. Vaiyani D; Kelleman M; Downey LA; Kanaan U; Petit CJ; Bauser-Heaton H Pediatr Cardiol; 2021 Apr; 42(4):736-742. PubMed ID: 33512547 [TBL] [Abstract][Full Text] [Related]
53. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease. Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131 [TBL] [Abstract][Full Text] [Related]
54. Atrial natriuretic peptide concentrations in children with pulmonary hypertension: correlation with hemodynamic measurements. Tunaoglu FS; Olgunturk FR; Gokcora N; Turkyilmaz C; Gurbuz F Pediatr Cardiol; 1994; 15(6):288-95. PubMed ID: 7838802 [TBL] [Abstract][Full Text] [Related]
55. The pulmonary vascular bed in children with Down syndrome. Chi TPL?Krovetz J J Pediatr; 1975 Apr; 86(4):533-8. PubMed ID: 123955 [TBL] [Abstract][Full Text] [Related]
58. Noninvasive assessment of pulmonary artery flow and resistance by cardiac magnetic resonance in congenital heart diseases with unrestricted left-to-right shunt. Bell A; Beerbaum P; Greil G; Hegde S; Toschke AM; Schaeffter T; Razavi R JACC Cardiovasc Imaging; 2009 Nov; 2(11):1285-91. PubMed ID: 19909932 [TBL] [Abstract][Full Text] [Related]
59. Dispersion durations of P-wave and QT interval in children with congenital heart disease and pulmonary arterial hypertension. Sap F; Karataş Z; Altin H; Alp H; Oran B; Baysal T; Karaarslan S Pediatr Cardiol; 2013 Mar; 34(3):591-6. PubMed ID: 22972516 [TBL] [Abstract][Full Text] [Related]
60. Circulating microRNA as a Novel Biomarker for Pulmonary Arterial Hypertension Due to Congenital Heart Disease. Chen W; Li S Pediatr Cardiol; 2017 Jan; 38(1):86-94. PubMed ID: 27837306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]